Neuroscience NewsTargeted Therapy Vorasidenib Offers Hope for Deadly Brain TumorsJun 4, 2023more_vert
PR NewswireServier Presents Transformational Data from Pivotal Phase 3 INDIGO Trial of Vorasidenib in Recurrent or Residual ...Jun 4, 2023more_vert